MET mutations boost #TumorImmunogenicity, enhance immune infiltration, and improve responses to #ImmuneCheckpointInhibitors, serving as independent #biomarkers for survival and guiding #PersonalizedImmunotherapy across cancers.
#OpenAccess: doi.org/10.1016/j.ge...

Analysis of pan-cancer ALK mutation characteristics reveals that ALK mutation enhances #TumorImmunogenicity & strengthens immune responses, marking it as a potential #Biomarker for favorable outcomes in immune checkpoint blockade.
#medsky

#OpenAccess: www.sciencedirect.com/science/arti...